This presentation explores NICE NG28 2026 Guideline Update for managing type 2 diabetes in adults. A major focus of our session is highlighting the key changes within this new update. Specifically, we will examine how the updated guidance defines new, tailored patient treatment categories based on specific co-morbidities to optimise proactive cardio-renal protection.

This is a promotional symposium sponsored and organised by A. Menarini Farmaceutica Internazionale SRL, for UK registered HCPs only.

PP-IN-UK-3391 | Date of prep: April 2026